Loading insider details...
Latest Form 4 (Sep 21, 2026): Grant/Award of 6,801 BDTX shares, $13.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 6,801 | $13.1K |
| Jun 29, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 40,000 | n/a |
| Jun 23, 2026 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 29,500 | n/a |
| Jun 22, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 7,907 | $13.1K |
| Apr 29, 2026 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 2,911 | n/a |
| Mar 20, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 6,105 | $13.1K |
| Dec 15, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 4,665 | $12.9K |
| Sep 22, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 3,843 | $12.9K |
| Jun 20, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 5,526 | $12.9K |
| Jun 12, 2025 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 30,550 | n/a |